跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LITAK cladribine 10mg/5mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
LITAK cladribine 10mg/5mL injection vial
Approved
STANDARD
LITAK cladribine 10mg/5mL injection vial
Viatris Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
eb2e9d6759386d0c
Company
Viatris Pty Ltd
Type
Standard
Approval Details
Approval Id
eb2e9d6759386d0c
Product Name
LITAK cladribine 10mg/5mL injection vial
Artg Id
104283
Artg Name
LITAK cladribine 10mg/5mL injection vial
Sponsor
Viatris Pty Ltd
Company Detail Path
/organization/viatris-pty-ltd
Artg Date
2004-07-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/01afca404baabca235f12ea228e623f9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/79bd8342932a18933d1d408d3cad6c15.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
eb2e9d6759386d0c
Type
Standard
Back to TGA Approvals